Paul A. Friedman

2020 - Synta Pharmaceuticals

In 2020, Paul A. Friedman earned a total compensation of $4.5M as Chairman and Chief Executive Officer at Synta Pharmaceuticals, a 26% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$463,446
Option Awards$3,468,500
Salary$603,500
Total$4,535,446

Friedman received $3.5M in option awards, accounting for 76% of the total pay in 2020.

Friedman also received $463.4K in non-equity incentive plan and $603.5K in salary.

Rankings

In 2020, Paul A. Friedman's compensation ranked 2,477th out of 13,090 executives tracked by ExecPay. In other words, Friedman earned more than 81.1% of executives.

ClassificationRankingPercentile
All
2,477
out of 13,090
81st
Division
Manufacturing
948
out of 5,618
83rd
Major group
Chemicals And Allied Products
341
out of 2,251
85th
Industry group
Drugs
292
out of 1,951
85th
Industry
Pharmaceutical Preparations
211
out of 1,456
86th
Source: SEC filing on May 2, 2022.

Friedman's colleagues

We found four more compensation records of executives who worked with Paul A. Friedman at Synta Pharmaceuticals in 2020.

2020

Brian Lynch

Synta Pharmaceuticals

General Counsel

2020

Rebecca Taub

Synta Pharmaceuticals

Chief Medical Officer

2020

Remy Sukhija

Synta Pharmaceuticals

Senior Vice President, Chief Commercial Officer

2020

Marc Schneebaum

Synta Pharmaceuticals

Chief Financial Officer

News

In-depth

You may also like